Lee, Kyung Hyeon
Ali, Nadia Fazal
Lee, Soo Hyeon
Zhang, Zhimin
Burdick, Marie
Beaulac, Zachary J.
Petruncio, Greg
Li, Linxia
Xiang, Jiangdong
Chung, Ezra M.
Foreman, Kenneth W.
Noble, Schroeder M.
Shim, Yun M.
Paige, Mikell
Funding for this research was provided by:
National Institutes of Health (R01HL132287, R01HL132287, R01HL132287, R01HL132287, R01HL132287, R01HL132287, R01HL132287)
Article History
Received: 30 December 2021
Accepted: 12 April 2022
First Online: 8 June 2022
Competing interests
: YMS and MP are co-inventors of Patent Application US13/814,087 entitled Compositions and Methods for Treating Inflammatory Disease, which includes 4MDM. KHL, GP, SMN, and MP’s works have been funded by NIH R01HL132287. ZZ, MB, and YMS’s works have been funded by NIH R01HL132177, NIH R01HL132287, NIH K08HL091127. NA, SHL, ZB, LL, JDX, EMC, and KWF declare no competing interests.